SODIUM P-(3-(P-CHLOROPHENYL)-4,5-DIHYDRO-1H-PYRAZOL-1-YL)BENZENESULPHINATE
UNII GU8NB7DM4Q
Substance Identification & Data
This profile provides standardized clinical and technical data for Sodium P-(3-(p-chlorophenyl)-4,5-dihydro-1h-pyrazol-1-yl)benzenesulphinate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) GU8NB7DM4Q.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 43037-46-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C15H12ClN2O2S.Na ZFCKILMXBFBMCM-UHFFFAOYSA-M Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Sodium P-(3-(p-chlorophenyl)-4,5-dihydro-1h-pyrazol-1-yl)benzenesulphinate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.